Livestock Vaccine Market Analysis 2026

Global Livestock Vaccine Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Livestock Vaccine Market Report Description

We have various report editions of Livestock Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Competitive Landscape of the Livestock Vaccine Market

Numerous small and major animal vaccine makers are in the industry, characterized by intense competition. The main factors influencing competitiveness are the quick uptake of veterinary preventative injections in conjunction with government-funded bulk vaccination purchases. Furthermore, prominent businesses often resort to different techniques, including partnerships, mergers and acquisitions, and new product releases, to maintain market share and broaden their product range.

Livestock Vaccine Industry News

In February 2021, Ceva collaborated with the French National Research Institute for Agriculture, Food, and Environment (INRAE) for research and development aimed at preventing infectious diseases of animal origin and enhancing animal health.

(Source: https://www.ceva.com/press-release/research-and-innovation-in-animal-health-a-strengthened-partnership-between-inrae-and-ceva-sante-animale/)

In January 2021, The Poulvac Procerta HVT-IBD vaccine was introduced by Zoetis to protect chickens from Infectious Bursal Disease (IBD). This expanded the range of recombinant vector vaccines offered by the company.

Top Companies Market Share in Livestock Vaccine Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North America Livestock Vaccine Market share was 40% of the total market

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. This significant portion can be linked to the high frequency of livestock and zoonotic illnesses that cause widespread animal fatalities. Furthermore, a significant number of well-known pharmaceutical companies are anticipated to contribute to the market's growth as they continuously work to expand their geographic reach and commercialize their vaccines on a broad scale. The growing pet population in the United States and the increasing prevalence of canine diseases are also important factors driving the regional market's growth. Vaccination against these diseases is becoming more widely used.

The Asia Pacific region is witnessing an increase in sales. Some key elements predicted to accelerate market expansion in the region are the anticipated increase in cattle and government initiatives, particularly in developing nations. According to the National Dairy Development Board, India's cow population increased from 190.9 million in 2012 to 192.5 million in 2019. Because of this, there is a need for vaccines in a nation with such a big cow population. The market is driven by significant R&D spending by numerous large competitors and increased efforts to commercialize veterinary vaccinations and inoculations at reasonable costs.

The current report Scope analyzes Livestock Vaccine Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Livestock Vaccine Market Analysis

According to Cognitive Market Research, the global livestock vaccine market size was estimated at USD 5514.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 2205.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031. The North American livestock vaccine market is expected to grow in the coming years, driven by rising demand for meat, milk, and eggs and growing awareness of animal health and welfare. The development of new and improved vaccines and increasing government support for animal health are expected to boost the market further. As the population of North America grows, so does the demand for animal-based protein sources. This drives demand for vaccines that can help keep livestock healthy and productive. Many governments in North America have strict regulations in place to prevent the spread of animal diseases. These regulations often require the use of vaccines for certain livestock populations.

• According to Cognitive Market Research, the US had a major share in the livestock vaccines market, with a market size of USD 1740.28 million in 2024, projected to grow at a CAGR of 2.5% during the forecast period. The US livestock vaccine market is expected to grow in the coming years, driven by the increasing demand for animal protein, rising awareness of animal welfare, and government support for animal health.
• The Canada livestock vaccines market had a market share of USD 264.68 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. The Canadian livestock vaccine market is a significant and growing sector within the animal health industry. It plays a crucial role in protecting the health and welfare of livestock animals, including cattle, swine, poultry, sheep, and goats, and contributes to the overall safety and security of the Canadian food supply.
• The Mexico livestock vaccines market is projected to grow at a CAGR of 3.2% during the forecast period, with a market size of USD 200.72 million in 2024.

Europe Livestock Vaccine Market Analysis

Cognitive Market Research shows a market value of USD 5514.2 million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031. Europe accounted for over 30% of the global market size of USD 1654.26 million. Animal protein is produced and consumed in large quantities throughout the European Union, where meat consumption is predicted to rise further in the years to come. To meet this requirement, a healthy population of animals is required. European regulations and customer preferences prioritize animal welfare and proactive actions to control animal diseases. To do this, vaccination is essential.

• The United Kingdom's livestock vaccines market had a market share of USD 277.92 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. Overall, the UK livestock vaccine market is mature and growing, with several positive factors driving its future development. 
• The French livestock vaccines market is projected to grow at a CAGR of 2.2% during the forecast period, with a market size of USD 152.19 million in 2024.
• According to Cognitive Market Research, the size of the German livestock vaccines market was valued at USD 327.54 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. Germany is a well-established and important player in the livestock vaccine market. The country is home to major producers and consumers of vaccines, and the market is expected to grow in the coming years.
• The Italian livestock vaccines market is projected to grow at a CAGR of 2.4% during the forecast period, with a market size of USD 142.27 million in 2024.
• The Russian livestock vaccines market is projected to grow at a CAGR of 2.0% during the forecast period, with a market size of USD 256.41 million in 2024.
• The Spanish livestock vaccines market is projected to grow at a CAGR of 2.1% during the forecast period, with a market size of USD 135.65 million in 2024.
• The Luxembourg livestock vaccines market is projected to grow at a CAGR of 3.1% during the forecast period, with a market size of USD 51.28 million in 2024.
• The Portuguese livestock vaccines market is projected to grow at a CAGR of 2.8% during the forecast period, with a market size of USD 34.74 million in 2024.
• The Greece livestock vaccines market is projected to grow at a CAGR of 3.3% during the forecast period, with a market size of USD 19.85 million in 2024.
• The rest of Europe's livestock vaccines market is projected to grow at a CAGR of 1.7% during the forecast period, with a market size of USD 256.41 million in 2024.

Asia Pacific Livestock Vaccine Market Analysis

According to Cognitive Market Research, the global livestock vaccine market size was estimated at USD 5514.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1268.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031. The Asia Pacific region is home to the world's largest livestock population, with China and India leading the way. This large and growing population is driving demand for vaccines to prevent and control. Farmers are becoming increasingly aware of the importance of animal health for productivity and profitability. This is leading to increased adoption of vaccines, as well as other animal health products and services.

• According to Cognitive Market Research, the size of the China livestock vaccines market was valued at USD 570.72 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. This growth is driven by factors such as rising demand for animal protein, increasing livestock population, growing awareness of animal health, and government initiatives to promote animal welfare.
• The Japan livestock vaccines market is projected to grow at a CAGR of 5.0% during the forecast period, with a market size of USD 175.02 million in 2024.
• The India livestock vaccines market had a market share of USD 152.19 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. The Indian livestock vaccine market is a promising sector with significant growth potential.
• The South Korean livestock vaccines market is projected to grow at a CAGR of 5.6% during the forecast period, with a market size of USD 126.83 million in 2024.
• The Australian livestock vaccines market is projected to grow at a CAGR of 6.2% during the forecast period, with a market size of USD 65.95 million in 2024.
• The Southeast Asia livestock vaccines market is projected to grow at a CAGR of 7.5% during the forecast period, with a market size of USD 87.51 million in 2024.
• The Rest of the Asia Pacific livestock vaccines market is projected to grow at a CAGR of 6.3% during the forecast period, with a market size of USD 90.05 million in 2024.

South America Livestock Vaccine Market Analysis

According to Cognitive Market Research, the global Livestock vaccines market size was estimated at USD 5514.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 275.71 million in 2024 and will grow at compound annual growth rate (CAGR) of 3.9% from 2024 to 2031. Latin America is home to some of the world's largest cattle, pigs, and poultry herds. Brazil, for example, is the world's largest beef exporter and the third-largest poultry producer. Farmers are becoming increasingly aware of the importance of vaccinating their animals to prevent diseases that can lead to significant economic losses. Many governments in Latin America provide financial and technical support for vaccination programs, helping boost vaccine demand.

• According to Cognitive Market Research, Brazil's livestock vaccines market was valued at USD 118.00 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Brazil is a major player in the global livestock sector, and its livestock vaccine market is poised for significant growth in the coming years.
• The Argentina livestock vaccines market had a share of USD 46.32 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. The Argentine livestock vaccine market is significant, driven by the country's large and important livestock industry.
• The Colombia livestock vaccines market is projected to grow at a CAGR of 3.7% during the forecast period, with a market size of USD 24.54 million in 2024.
• The Peru livestock vaccines market is projected to grow at a CAGR of 4.1% during the forecast period, with a market size of USD 22.61 million in 2024.
• The Chile livestock vaccines market is projected to grow at a CAGR of 4.2% during the forecast period with a market size of USD 19.85 million in 2024.
• The Rest of the Latin American livestock vaccines market is projected to grow at a CAGR of 3.0% during the forecast period, with a market size of USD 44.39 million in 2024.

Middle East Livestock Vaccine Market Analysis

According to Cognitive Market Research, the global livestock vaccine market size was estimated at USD 5514.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 110.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031. The growing demand for meat, milk, and other animal products will likely fuel a large increase in the number of livestock in the MEA region in the upcoming years. More vaccinations are becoming necessary as a result of shielding animals from illness. Farmers in the MEA region are prepared to spend money on vaccines to protect their animals because they recognize how important animal health is. The main drivers are government campaigns, educational initiatives, disease outbreaks like peste des petits ruminants, and foot-and-mouth disease.

• According to Cognitive Market Research, the GCC Countries' livestock vaccines market size was valued at USD 47.20 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. The growing population and increasing disposable incomes in the GCC region are leading to a rise in the demand for animal protein, such as meat, milk, and eggs. This drives the need for healthy livestock and increased adoption of livestock vaccines.
• The Egyptian livestock vaccines market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 11.58 million in 2024.
• The South African livestock vaccines market is projected to grow at a CAGR of 5.2% during the forecast period, with a market size of USD 17.42 million in 2024. The future of the South African livestock vaccine market is uncertain, but several factors could lead to growth in the coming years. These include increasing government support, private sector investment, and innovation.
• The Turkish livestock vaccines market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 9.48 million in 2024.
• The Nigeria livestock vaccines market is projected to grow at a CAGR of 3.3% during the forecast period, with a market size of USD 11.58 million in 2024.
• The Rest of the MEA livestock vaccines market is projected to grow at a CAGR of 3.2% during the forecast period, with a market size of USD 13.01 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.